FTC Redefines Which Drug Patent Deals Need Antitrust OK

FTC Redefines Which Drug Patent Deals Need Antitrust OK

The Federal Trade Commission has revised the rules dictating when pharmaceutical companies must report a transfer of exclusive patent rights to the U.S. Department of Justice and the FTC for antitrust review and approval, the agency announced Wednesday ...read more

  • Tags: